ApprovalTrail

Drug · DIN 02556561

MILEY 28

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since August 18, 2025; first marketed August 18, 2025.
Drug Identification Number (DIN)
02556561
Company (DIN owner)
Ambicare Pharmaceuticals Inc.Oakville, Ontario, Canada
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Desogestrel and estrogen G03AA09
Class
Human
Record last updated
September 3, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DESOGESTREL0.15 MG
ETHINYL ESTRADIOL0.03 MG

Notices of Compliance

Health Canada approvals that name this DIN.